The Lipoatrophy Resource Center -

Show Archived (Historical) Articles

A Facial Filler Needs a Dose of Patience (September 23, 2009)
In The New York Times
FDA Warns Consumers to Stop Using Hydroxycut Products (May 1, 2009)
From U.S. Food and Drug Administration
Cosmetic Treatment for Facial Fat Loss Safe and Effective in the Long Term (April 27, 2009)
From aidsmap.com
Leptin Injections May Help HIVers With Lipoatrophy, Other Metabolic Problems, According to Small Study (April 2009)
The full text of a study published in the Journal of Clinical Endocrinology & Metabolism.
From National AIDS Treatment Advocacy Project
Whither Recombinant Human Leptin Treatment for HIV-Associated Lipoatrophy and the Metabolic Syndrome? (April 2009)
Christos Mantzoros, M.D., an associate professor at Harvard Medical School, offers his take on whether there's a future for leptin replacement as a treatment for metabolic complications in people with HIV. (Editorial originally published in the Journal of Clinical Endocrinology & Metabolism.)
From National AIDS Treatment Advocacy Project
Body Shape Changes Dramatically Impact the Self-Esteem of HIV-Positive People (April 15, 2009)
Nelson Vergel, a longtime HIV activist and 26-year survivor of HIV, created an anonymous Internet survey that asks people with HIV to detail the impact of body shape changes on their quality of life and self esteem.
From The Body
Can Low-Dose Ritonavir Help Preserve Body Shape? (April 1, 2009)
In CATIE News, from Canadian AIDS Treatment Information Exchange
This Month in HIV: 2009 Update on Body Shape Changes and HIV/AIDS (April 2009)
HIV activist and long-time survivor Nelson Vergel leads a discussion with Donald Kotler, M.D., who is an expert on metabolic complications and HIV. They fill us in on some of the latest updates regarding fat loss and fat gain in people with HIV.
In This Month in HIV, from The Body
Sculptra Continues to Increase Facial Volume More Than Six Months After Injections, Study Finds (January 4, 2009)
An abstract of a published study.
In HIV Medicine
Soria Announces the Addition of Lipoatrophy Repairing Treatment to the Common Services Portfolio of the National Health System (August 4, 2008)
To read PDF, click here
From Ministerio de Sanidad Y Consumo
U.S. Study Confirms Long-Term Use of AZT, d4T Result in Lipoatrophy (May 27, 2008)
From aidsmap.com
Taking a Half Dose of d4T Doesn't Reduce Fat Loss (April 16, 2008)
From aidsmap.com
Genetics May Protect Some From Lipoatrophy (March 18, 2008)
From aidsmap.com
Study Looks at How Much Fat a Person Can Lose Without Noticing It (February 11, 2008)
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Metabolic Complications Myths (November/December 2007)
A fascinating look at some of the myths about body shape changes associated with HIV and HIV treatment.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Switching to NRTIs Less Associated With Lipoatrophy Is Successful (July 25, 2007)
Since thymidine-sparing, NRTI-based regimens are associated with fewer instances of lipoatrophy and hyperlipidemia than thymidine-containing, NRTI-based regimens, switching to a thymidine-sparing, fixed-dose combination of NRTIs is feasible and associated with no unexpected adverse events, including those affecting renal function and bone mineral density. Graeme Moyle, M.D., reports.
In 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO
Canadian Study Finds Bio-Alcamid Safe, Effective for Facial Lipoatrophy (May 22, 2007)
From aidsmap.com
Hepatitis C Coinfection Doesn't Increase the Risk of Lipoatrophy (May 21, 2007)
A pair of new U.S. studies appears to contradict long-held concerns that HIV/hepatitis C-coinfected people have a higher risk of diabetes and lipoatrophy (fat loss).
From aidsmap.com
Glitazones Do Not Reverse Lipoatrophy (May 8, 2007)
From AIDSMeds.com
CROI: Kaletra Less Likely to Cause Fat Loss Than Efavirenz When Paired With NRTIs (February 28, 2007)
From aidsmap.com
FDA Approves Radiesse for Treating Facial Lipoatrophy (December 29, 2006)
From U.S. Food and Drug Administration
Is Lipoatrophy Related to Overactivity of Nervous System? (March 15, 2006)
From aidsmap.com
California Advocates Push for Insurance Coverage for Fat-Loss Treatment (March 13, 2006)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Steroid Restores Muscle and Fat Lost to AIDS Wasting (March 9, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
First-Ever Lipo-Linked Genes Are Seen (February 27, 2006)
From aidsmap.com
After Ditching d4T, Kids With Lipoatrophy Do Not See Fat Regain (February 24, 2006)
From aidsmap.com
Earlier HAART Start Reduces Risk of Lipo Side Effects (February 8, 2006)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Research in Anti-Lipo Therapy Headlines AIDS Confab (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Truvada Trumps Combivir in Lipoatrophy-Friendly Stakes (January 23, 2006)
From aidsmap.com

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.